Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.1 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.1 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.459NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.459NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.117NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.117NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.381NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.381NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.237NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.237NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.382NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.382NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.395NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.395NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.323NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.323NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FU.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FU.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FN.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FN.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.74NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.74NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.53NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.53NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HV.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HV.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.405NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.405NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.282NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.282NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.228NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
B.1.1.228NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.174NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
B.1.1.174NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.88 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.88 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.312NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.312NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.13.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.13.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.220NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.220NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.142NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.142NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.523NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used